tirzepatide breastfeeding data no longer contraindicated during The Breast Help — Weight

2010 Sep;27(3):942-5

Prescription medications to treat overweight and obesity

Clinical trials indicate that Tirzepatide demonstrates greater effectiveness in lowering blood sugar and promoting weight loss compared to semaglutide

Inter-assay coefficient of variations (CVs) were 8.1, 6.6, and 13.6, and intra-assay CVs were 1.9, 2.3, and 5.5 for whole blood SOD, GPx, and CAT activities, respectively

Tiered pricing models, bundling medication with structured coaching or digital programs, can create predictable cost structures

So far these meds seem a godsend for many individuals. For those considering starting GLP-1 medications, Bert advised talking to their physician and endocrinologist, and make sure to have an annual eye exam